tiprankstipranks
Heidelberg Pharma AG (DE:HPHA)
XETRA:HPHA
Germany Market
HPHA
Heidelberg Pharma AG
RESEARCH TOOLSreports

Heidelberg Pharma AG (HPHA) Income Statement

6 Followers

Heidelberg Pharma AG Income Statement

Last quarter (Q4 2025), Heidelberg Pharma AG's total revenue was €21.44K, a decrease of -98.31% from the same quarter last year. In Q4, Heidelberg Pharma AG's net income was €-21.23M. See Heidelberg Pharma AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Nov 25Feb 25Feb 24Feb 23Feb 22
Total Revenue
€ 1.46M€ 6.85M€ 9.86M€ 18.51M€ 1.75M
Gross Profit
€ -1.63M€ 4.20M€ 6.61M€ 13.83M€ -2.96M
Operating Expenses
€ 45.81M€ 25.73M€ 27.82M€ 32.17M€ 22.83M
Depreciation and Amortization
€ 2.82M€ 871.22K€ 879.00K€ 756.58K€ 802.86K
EBITDA
€ -44.63M€ -18.37M€ -18.71M€ -16.19M€ -24.83M
Operating Income
€ -47.44M€ -24.56M€ -21.21M€ -18.33M€ -25.63M
Other Income/Expenses
€ 6.21M€ 1.28M€ 863.31K€ -604.67K€ -507.64K
Pretax Income
€ -41.23M€ -19.38M€ -20.35M€ -17.79M€ -26.14M
Net Income
€ -42.28M€ -19.38M€ -20.35M€ -19.70M€ -26.63M
Per Share Metrics
Basic EPS
€ -0.91€ -0.42€ -0.44€ -0.53€ -0.82
Diluted EPS
€ -0.91€ -0.42€ -0.44€ -0.53€ -0.82
Weighted Average Shares Outstanding
 46.67M 46.60M 46.60M 37.24M 32.50M
Weighted Average Shares Outstanding (Diluted)
 46.67M 46.60M 46.60M 37.24M 32.50M
Currency in EUR

Heidelberg Pharma AG Earnings and Revenue History